Apart from this, CAR-T therapy offers a significant advantage over traditional immunotherapy due to its independence from MHC restriction, as immune evasion by cancer cells is mainly caused by a lack of MHC-associated antigen presentation (16). Here, HLA-C is linked to cancer.